Torrent Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
January 25, 2023 at 07:35 am EST
Share
Torrent Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 24,590 million compared to INR 20,920 million a year ago. Revenue was INR 24,810 million compared to INR 21,560 million a year ago. Net income was INR 2,830 million compared to INR 2,490 million a year ago. Basic earnings per share from continuing operations was INR 8.36 compared to INR 7.37 a year ago. Diluted earnings per share from continuing operations was INR 8.36 compared to INR 7.37 a year ago.
For the nine months, sales was INR 70,120 million compared to INR 63,150 million a year ago. Revenue was INR 71,650 million compared to INR 65,180 million a year ago. Net income was INR 9,490 million compared to INR 8,950 million a year ago. Basic earnings per share from continuing operations was INR 28.02 compared to INR 26.45 a year ago. Diluted earnings per share from continuing operations was INR 28.02 compared to INR 26.45 a year ago.
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
TORRENT PHARMACEUTICALS LIMITED 
